Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 10 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
10
Total Funding
$678.1M
Avg Funding
$67.8M
Cities
10

Export 10 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Charlestown, United States
$240.0M
raised

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

San Diego, United States
$6.0M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Branford, United States
$31.0M
raised

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 10 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Sioux Falls, United States
$85.0M
raised

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$100.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Los Altos, United States
$120.0M
raised

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

La Jolla, United States
$35.0M
raised

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Miami, United States
$30.0M
raised

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 10 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked